OLANZAPINE ODT TEVA ® 5 MG

Land: Israel

Sprache: Englisch

Quelle: Ministry of Health

Wirkstoff:

OLANZAPINE 5 MG

Verfügbar ab:

SALOMON,LEVIN & ELSTEIN LTD

ATC-Code:

N05AH03

Darreichungsform:

TABLETS ORODISPERSIBLE

Verabreichungsweg:

PER OS

Hergestellt von:

TEVA OPERATIONS POLAND SP.ZO.O

Therapiegruppe:

OLANZAPINE

Anwendungsgebiete:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Berechtigungsdatum:

2011-05-01